135 related articles for article (PubMed ID: 37596331)
1. Curcumin and melphalan cotreatment induces cell cycle arrest and apoptosis in MDA-MB-231 breast cancer cells.
Passos CLA; Polinati RM; Ferreira C; Dos Santos NAN; Lima DGV; da Silva JL; Fialho E
Sci Rep; 2023 Aug; 13(1):13446. PubMed ID: 37596331
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol chemosensitizes breast cancer cells to melphalan by cell cycle arrest.
Casanova F; Quarti J; da Costa DC; Ramos CA; da Silva JL; Fialho E
J Cell Biochem; 2012 Aug; 113(8):2586-96. PubMed ID: 22415970
[TBL] [Abstract][Full Text] [Related]
3. Proinflammatory cytokine profile is critical in autocrine GH-triggered curcumin resistance engulf by atiprimod cotreatment in MCF-7 and MDA-MB-231 breast cancer cells.
Coker-Gurkan A; Ozakaltun B; Akdeniz BS; Ergen B; Obakan-Yerlikaya P; Akkoc T; Arisan ED
Mol Biol Rep; 2020 Nov; 47(11):8797-8808. PubMed ID: 33130987
[TBL] [Abstract][Full Text] [Related]
4. Curcumin analogue 1,5-bis(4-hydroxy-3-((4-methylpiperazin-1-yl)methyl)phenyl)penta-1,4-dien-3-one mediates growth arrest and apoptosis by targeting the PI3K/AKT/mTOR and PKC-theta signaling pathways in human breast carcinoma cells.
Badr G; Gul HI; Yamali C; Mohamed AAM; Badr BM; Gul M; Abo Markeb A; Abo El-Maali N
Bioorg Chem; 2018 Aug; 78():46-57. PubMed ID: 29533214
[TBL] [Abstract][Full Text] [Related]
5. Curcumin-induced Aurora-A suppression not only causes mitotic defect and cell cycle arrest but also alters chemosensitivity to anticancer drugs.
Ke CS; Liu HS; Yen CH; Huang GC; Cheng HC; Huang CY; Su CL
J Nutr Biochem; 2014 May; 25(5):526-39. PubMed ID: 24613085
[TBL] [Abstract][Full Text] [Related]
6. Effect of bis(hydroxymethyl) alkanoate curcuminoid derivative MTH-3 on cell cycle arrest, apoptotic and autophagic pathway in triple-negative breast adenocarcinoma MDA-MB-231 cells: An in vitro study.
Chang LC; Hsieh MT; Yang JS; Lu CC; Tsai FJ; Tsao JW; Chiu YJ; Kuo SC; Lee KH
Int J Oncol; 2018 Jan; 52(1):67-76. PubMed ID: 29138806
[TBL] [Abstract][Full Text] [Related]
7. ST09, A Novel Curcumin Derivative, Blocks Cell Migration by Inhibiting Matrix Metalloproteases in Breast Cancer Cells and Inhibits Tumor Progression in EAC Mouse Tumor Models.
Nirgude S; Mahadeva R; Koroth J; Kumar S; Kumar KSS; Gopalakrishnan V; S Karki SS; Choudhary B
Molecules; 2020 Sep; 25(19):. PubMed ID: 33008036
[TBL] [Abstract][Full Text] [Related]
8. Curcumin inhibits autocrine growth hormone-mediated invasion and metastasis by targeting NF-κB signaling and polyamine metabolism in breast cancer cells.
Coker-Gurkan A; Celik M; Ugur M; Arisan ED; Obakan-Yerlikaya P; Durdu ZB; Palavan-Unsal N
Amino Acids; 2018 Aug; 50(8):1045-1069. PubMed ID: 29770869
[TBL] [Abstract][Full Text] [Related]
9. Cycle arrest and apoptosis in MDA-MB-231/Her2 cells induced by curcumin.
Sun SH; Huang HC; Huang C; Lin JK
Eur J Pharmacol; 2012 Sep; 690(1-3):22-30. PubMed ID: 22705896
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic treatment with anionic nanoclays containing curcumin on human triple-negative breast cancer cells: Cellular and biochemical studies.
Khorsandi K; Hosseinzadeh R; Shahidi FK
J Cell Biochem; 2019 Apr; 120(4):4998-5009. PubMed ID: 30302810
[TBL] [Abstract][Full Text] [Related]
11. RL71, a second-generation curcumin analog, induces apoptosis and downregulates Akt in ER-negative breast cancer cells.
Yadav B; Taurin S; Larsen L; Rosengren RJ
Int J Oncol; 2012 Sep; 41(3):1119-27. PubMed ID: 22710975
[TBL] [Abstract][Full Text] [Related]
12. Curcumin analog B14 has high bioavailability and enhances the effect of anti-breast cancer cells in vitro and in vivo.
Shen H; Shen J; Pan H; Xu L; Sheng H; Liu B; Yao M
Cancer Sci; 2021 Feb; 112(2):815-827. PubMed ID: 33316116
[TBL] [Abstract][Full Text] [Related]
13. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
[TBL] [Abstract][Full Text] [Related]
14. The novel camptothecin derivative, CPT211, induces cell cycle arrest and apoptosis in models of human breast cancer.
Chiu CF; Lin YQ; Park JM; Chen YC; Hung SW; Chiu CC; Chang CF
Biomed Pharmacother; 2020 Aug; 128():110309. PubMed ID: 32505820
[TBL] [Abstract][Full Text] [Related]
15. Gene Expression Alterations Associated with Oleuropein-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Triple-Negative Breast Cancer Cells.
Messeha SS; Zarmouh NO; Asiri A; Soliman KFA
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33297339
[TBL] [Abstract][Full Text] [Related]
16. Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NF-kappaBp65 expression in breast cancer MDA-MB-231 cells.
Chiu TL; Su CC
Int J Mol Med; 2009 Apr; 23(4):469-75. PubMed ID: 19288022
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic Effect of Gemini Curcumin on MDA-MB-468 Breast Cancer Cell Line.
Hajizadeh M; Ghoran SH; Azeez HJ; Feizi MAH; Babaei E
Anticancer Agents Med Chem; 2022; 22(11):2181-2188. PubMed ID: 34773965
[TBL] [Abstract][Full Text] [Related]
18. Curcumin-Celecoxib: a synergistic and rationale combination chemotherapy for breast cancer.
Alqahtani AM; Chidambaram K; Pino-Figueroa A; Chandrasekaran B; Dhanaraj P; Venkatesan K
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1916-1927. PubMed ID: 33660801
[TBL] [Abstract][Full Text] [Related]
19. The Curcumin Analog PAC Is a Potential Solution for the Treatment of Triple-Negative Breast Cancer by Modulating the Gene Expression of DNA Repair Pathways.
Almalki E; Al-Amri A; Alrashed R; Al-Zharani M; Semlali A
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298600
[TBL] [Abstract][Full Text] [Related]
20. 1,2,3,4,6-penta-O-galloyl-β-D-glucose, quercetin, curcumin and lycopene induce cell-cycle arrest in MDA-MB-231 and BT474 cells through downregulation of Skp2 protein.
Huang HC; Lin CL; Lin JK
J Agric Food Chem; 2011 Jun; 59(12):6765-75. PubMed ID: 21598989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
